Quantcast
Home > Quotes > ALKS
ALKS

Alkermes plc Ordinary Shares (ALKS) Quote & Summary Data

$33.36
*  
0.51
1.51%
Get ALKS Alerts
*Delayed - data as of Nov. 14, 2018 14:40 ET  -  Find a broker to begin trading ALKS now
Exchange:NASDAQ
Industry: Health Care
Community Rating:
View:    ALKS Real Time
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks

Key Stock Data

Best Bid / Ask
$ 33.35 / $ 33.38
1 Year Target
43
Today's High / Low
$ 34.29 / $ 32.77
Share Volume
520,918
50 Day Avg. Daily Volume
851,652
Previous Close
$ 33.87
52 Week High / Low
$ 71.22 / $ 33.80
Market Cap
5,183,569,774
P/E Ratio
NE
Forward P/E (1y)
NE
Earnings Per Share (EPS)
$ -0.89
Annualized Dividend
N/A
Ex Dividend Date
N/A
Dividend Payment Date
N/A
Current Yield
0 %
Beta
1.86

Intraday Chart

Shares Traded

Share Volume:
520,918
50 Day Avg. Daily Volume:
851,652

P/E Ratio

P/E Ratio:
NE
Forward P/E (1y):
NE
Earnings Per Share (EPS):
$ -0.89

Trading Range

The current last sale of $33.36 is -1.30% Lower than the 52 week low.

Intraday Last 52 Weeks
High: $ 34.29 $ 71.22
 Low: $ 32.77 $ 33.80

Company Description (as filed with the SEC)

The following discussion contains forward­looking statements. Actual results may differ significantly from those expressed or implied in the forward­looking statements. See "Cautionary Note Concerning Forward­Looking Statements" on page 3 of this Annual Report. Factors that might cause future results to differ materially from those expressed or implied in the forward­looking statements include, but are not limited to, those discussed in "Item 1A--Risk Factors" and elsewhere in this Annual Report. Overview Alkermes plc is a fully integrated, global biopharmaceutical company that applies its scientific expertise and proprietary technologies to research, develop and commercialize, both with partners and on its own, pharmaceutical products that are designed to address unmet medical needs of patients in major therapeutic areas.  ... More ...  


Risk Grade

Where does ALKS fit in the risk graph?


Risk Grade Scale

Nasdaq Official Price

Open Price:
$ 33.87
Open Date:
Nov. 14, 2018
Close Price:
$ 33.87
Close Date:
Nov. 13, 2018

Consensus Recommendation

Analyst Info



Another Bailout?? Why is the SEC boosting big banks and HFT's bottom lines?
x